These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


217 related items for PubMed ID: 900461

  • 1. Drug treatment of malignant hyperpyrexia.
    Austin KL, Denborough MA.
    Anaesth Intensive Care; 1977 Aug; 5(3):207-13. PubMed ID: 900461
    [Abstract] [Full Text] [Related]

  • 2. Rationale for dantrolene vs. procainamide for treatment of malignant hyperthermia.
    Nelson TE, Flewellen EH.
    Anesthesiology; 1979 Feb; 50(2):118-22. PubMed ID: 434484
    [Abstract] [Full Text] [Related]

  • 3. Dantrolene--in vitro studies in malignant hyperthermia susceptible (MHS) and normal skeletal muscle.
    Britt BA, Scott E, Frodis W, Clements MJ, Endrenyi L.
    Can Anaesth Soc J; 1984 Mar; 31(2):130-54. PubMed ID: 6704779
    [Abstract] [Full Text] [Related]

  • 4. Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.
    Harrison GG.
    Br J Anaesth; 1975 Jan; 47(1):62-5. PubMed ID: 1148076
    [Abstract] [Full Text] [Related]

  • 5. Porcine malignant hyperthermia: effect of dantrolene sodium on in-vitro halothane-induced contraction of susceptible muscle.
    Anderson IL, Jones EW.
    Anesthesiology; 1976 Jan; 44(1):57-61. PubMed ID: 1244776
    [Abstract] [Full Text] [Related]

  • 6. An evaluation of procaine in the treatment of malignant hyperpyrexia.
    Clarke IM, Ellis FR.
    Br J Anaesth; 1975 Jan; 47(1):17-21. PubMed ID: 1148070
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of porcine malignant hyperpyrexia. The successful use of dantrolene in the Pietrain pig.
    Hall GM, Lucke JN, Lister D.
    Anaesthesia; 1977 May; 32(5):472-4. PubMed ID: 869147
    [Abstract] [Full Text] [Related]

  • 10. Procaine in malignant hyperpyrexia.
    Moulds RF, Denborough MA.
    Br Med J; 1972 Dec 02; 4(5839):526-8. PubMed ID: 4642792
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of diltiazem, verapamil and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible human skeletal muscle.
    Foster PS, Hopkinson KC, Denborough MA.
    Clin Exp Pharmacol Physiol; 1989 Oct 02; 16(10):799-805. PubMed ID: 2612062
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [In vitro diagnosis of malignant hyperpyrexia syndrome].
    Eldar I, Goldberg G, Glauber V, Perel A.
    Harefuah; 1991 Dec 15; 121(12):499-502. PubMed ID: 1794753
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human malignant hyperthermia: awake episodes and correction by dantrolene.
    Gronert GA, Thompson RL, Onofrio BM.
    Anesth Analg; 1980 May 15; 59(5):377-8. PubMed ID: 7189384
    [No Abstract] [Full Text] [Related]

  • 18. Malignant hyperthermia. Considerations for the ophthalmologist.
    Sedwick LA, Romano PE.
    Surv Ophthalmol; 1981 May 15; 25(6):378-82. PubMed ID: 7245023
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The chick as a model for malignant hyperpyrexia.
    Korczyn AD, Shavit S, Shlosberg I.
    Eur J Pharmacol; 1980 Jan 25; 61(2):187-9. PubMed ID: 7353589
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.